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BACKGROUND AND RATIONALE
Increased chocolate consumption has been linked with reduced risks of development of cardio-metabolic disorders. 1 Additionally, national variation in chocolate consumption is positively correlated with the number of Nobel laureates per unit population. 2 Chocolate consumption in a hospital environment is a relatively common occurrence and gifts from patients and families represent a large proportion of healthcare workers' chocolate consumption. Anecdotal evidence suggests that different prepackaged chocolate varieties seemed to last different lengths of time, and which healthcare professionals ate all the chocolates seems to be a common source of workplace conflict.
The aims of the study are to try to identify variations in chocolate consumption amongst healthcare workers in a hospital environment by looking at: . Both boxes of chocolates will be placed side by side and anonymously on the main reception/nurses desk of the wards chosen. One of the study personnel will sit and observe both boxes and record information on a preprinted case-report form (Appendix 1).
We are aiming to collect data from four wards -a general surgical ward (Great Western Hospital, Swindon), a medicals admission unit and a general medical ward (Bedford Hospital, Bedford), and a haematology ward (University Hospital of North Staffordshire, Stoke-on-Trent).
Primary Outcome Measures
• Mean survival time (from the box being opened) of an individual chocolate measured by Kaplan-Meier analysis
Secondary Outcome Measures
• Time to box being opened 
Subgroup Analysis

Inclusion/Exclusion Criteria
All chocolate eaters will be included, no exclusion criteria are present.
Methods
The chocolate boxes will be placed on individual wards without explanation or warning between 0900-1000. They will be placed side by side in a main central location determined by the observer. The boxes will remain under continuous visual surveillance by observers who are familiar with the ward, staff and their roles. The observer will not outwardly show that they are observing the chocolates and will as such be covert. The observer will record data on the attached data collection form (Appendix 1) until both chocolate boxes have emptied. The observer will not be on patient-care duties during the time of observation.
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Details of the Intervention
Standard 350 g Roses boxes manufactured by Cadbury, UK and standard 350 g Quality Street boxes manufactured by Nestlé, Switzerland will be used.
Supplies
The costs of the boxes were calculated and an equal share paid individually by all the study authors. No external funds will be used.
Study End
The study will end once data has been collected on both boxes from all four locations.
Adverse Events
Definitions
Adverse event (AE): any untoward medical occurrence in a clinical study subject. Serious Adverse Event (SAE): any untoward or unexpected medical occurrence or effect that results in death, is life threatening, requires hospitalisation or results in persistent or significant disability or incapacity.
Medical judgment will be exercised in deciding whether an AE is serious in other situations. Important AEs that are not immediately life-threatening or do not result in death or hospitalisation but may jeopardise the subject or may require intervention to prevent one of the other outcomes listed in the definition above, should also be considered serious.
All adverse and serious adverse events will be reported. Other than allergic reactions we do not anticipate any events.
Statistical Analysis
Kaplan-Meier survival analysis will be used to analyse the primary outcome. Data will be pooled and also analysed separately by type of chocolate, ward and role of consumer. Other continuous variables will be analysed by independent sample t-tests with a significance level of 0.05. No previous studies are available to base power calculations on. A total of 210 chocolates will provide 80% power (P<0.05, 2-sided) to detect a 50% change in the hazard ratio between groups assuming a median survival of 60 minutes for an individual chocolate and follow-up of 4 hours maximum. 3 Assuming a 350g box of chocolates contains 30 chocolates, we will be using a total of 240 chocolates.
Regulatory Issues
Ethical Issues
We did not seek ethical approval for the study. No identifiable individual data will be collected. We considered the effects of the availability of additional chocolate resulting in weight gain in vulnerable subjects. Given the free availability of such products and the fact that no coercion will be present we deem this a minor issue.
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Additionally, the amounts of chocolate likely to be consumed by a single individual as a result of our study are small. There is a small risk of allergic reactions but we felt that given the free availability of these brands throughout the hospital, it would be unlikely that this would be a significant and unknown risk to participants. The study will be conducted in accordance with the recommendations for physicians involved in research on human subjects adopted by the 18th World Medical Assembly, Helsinki 1964 and later revisions.
Consent
No identifiable data is being collected, and we are not planning to seek prior consent from participants as this will bias the study significantly. We have weighed up the risks and benefits and feel that this is justified given that the benefits/harm to the individual person of eating a chocolate is best assessed by the free will of the individual participant.
Funding
The study will be funded by the authors equally from personal funds. 
